ProfileGDS4718 / 224878_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 83% 82% 86% 84% 80% 91% 90% 82% 79% 84% 83% 74% 86% 91% 88% 86% 83% 87% 89% 86% 84% 83% 82% 83% 85% 90% 79% 92% 80% 89% 87% 92% 77% 82% 89% 93% 87% 83% 82% 87% 80% 89% 90% 93% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.1880483
GSM549102patient 115, normal, homogenized [OPG study]8.0681382
GSM549104patient 119, normal, homogenized [OPG study]8.6853286
GSM549108patient 138, normal, homogenized [OPG study]8.1773584
GSM549119patient 077, normal, homogenized [OPG study]7.7855780
GSM549133patient 032, cancer, homogenized [OPG study]9.537591
GSM549139patient 042, cancer, homogenized [OPG study]9.1774790
GSM549099patient 107, normal, homogenized [OPG study]8.0350982
GSM549109patient 139, normal, homogenized [OPG study]7.6571479
GSM549110patient 046, normal, homogenized [OPG study]8.2953984
GSM549114patient 063, normal, homogenized [OPG study]8.3468983
GSM549122patient 082, normal, homogenized [OPG study]7.2761374
GSM549134patient 033, cancer, homogenized [OPG study]8.6484386
GSM549136patient 036, cancer, homogenized [OPG study]9.3697691
GSM549140patient 044, cancer, homogenized [OPG study]8.9353288
GSM549111patient 047, normal, homogenized [OPG study]8.7344386
GSM549113patient 057, normal, homogenized [OPG study]8.3830383
GSM549132patient 031, cancer, homogenized [OPG study]8.7716187
GSM549137patient 038, cancer, homogenized [OPG study]8.9842189
GSM549142patient 047, cancer, homogenized [OPG study]8.2402986
GSM549100patient 110, normal, homogenized [OPG study]8.2343884
GSM549107patient 135, normal, homogenized [OPG study]8.2084283
GSM549115patient 068, normal, homogenized [OPG study]8.2435382
GSM549116patient 072, normal, homogenized [OPG study]8.3243283
GSM549120patient 078, normal, homogenized [OPG study]8.4482385
GSM549131patient 030, cancer, homogenized [OPG study]9.2778490
GSM549118patient 074, normal, homogenized [OPG study]7.7722479
GSM549129patient 027, cancer, homogenized [OPG study]9.3571492
GSM549123patient 088, normal, homogenized [OPG study]7.8851880
GSM549124patient 006, cancer, homogenized [OPG study]8.8443389
GSM549126patient 015, cancer, homogenized [OPG study]8.6761287
GSM549128patient 025, cancer, homogenized [OPG study]9.5078192
GSM549103patient 117, normal, homogenized [OPG study]7.4214177
GSM549117patient 073, normal, homogenized [OPG study]8.1040682
GSM549138patient 041, cancer, homogenized [OPG study]9.0983489
GSM549141patient 045, cancer, homogenized [OPG study]9.7784393
GSM549130patient 028, cancer, homogenized [OPG study]8.5949487
GSM549101patient 111, normal, homogenized [OPG study]8.1371183
GSM549105patient 128, normal, homogenized [OPG study]7.9921382
GSM549106patient 134, normal, homogenized [OPG study]8.9308787
GSM549112patient 048, normal, homogenized [OPG study]7.9182380
GSM549125patient 011, cancer, homogenized [OPG study]8.9960689
GSM549127patient 024, cancer, homogenized [OPG study]9.053190
GSM549135patient 035, cancer, homogenized [OPG study]9.7216493